Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
The proposed amendment aims at a) Clarifying scope of adverse events that should be reported to the Minister of Food and Drug Safety; and b) Setting up detailed provisions specific to the ones that should be reported to the Minister of Food and Drug Safety when a manufacturer or an importer, etc. distributes medical devices to medical institutions, etc.
Draft Text 1 is available for download in the following languages: Korean
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions